These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinicopathological analysis of malignant nephrosclerosis]. Hoshi S, Yamaguchi Y, Sanaka T, Hosoya T. Nihon Jinzo Gakkai Shi; 2008; 50(4):488-98. PubMed ID: 18546880 [Abstract] [Full Text] [Related]
3. [Vascular mechanisms of renal fibrosis. Vasculonephropathies and arterial hypertension]. Meyrier A. Bull Acad Natl Med; 1999; 183(1):33-45; discussion 45-6. PubMed ID: 10371763 [Abstract] [Full Text] [Related]
4. Glomerular Density in Biopsy-Proven Hypertensive Nephrosclerosis. Haruhara K, Tsuboi N, Kanzaki G, Koike K, Suyama M, Shimizu A, Miyazaki Y, Kawamura T, Ogura M, Yokoo T. Am J Hypertens; 2015 Sep; 28(9):1164-71. PubMed ID: 25631380 [Abstract] [Full Text] [Related]
5. Mechanisms in nephrosclerosis and hypertension-beyond hemodynamics. Fogo AB. J Nephrol; 2001 Sep; 14 Suppl 4():S63-9. PubMed ID: 11798148 [Abstract] [Full Text] [Related]
12. Effects of renin-angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis. Imakiire T, Kikuchi Y, Yamada M, Kushiyama T, Higashi K, Hyodo N, Yamamoto K, Oda T, Suzuki S, Miura S. Hypertens Res; 2007 Jul; 30(7):635-42. PubMed ID: 17785932 [Abstract] [Full Text] [Related]
13. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R. Kidney Int; 1997 Jan; 51(1):244-52. PubMed ID: 8995739 [Abstract] [Full Text] [Related]
14. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation. Hill GS, Heudes D, Bariéty J. Kidney Int; 2003 Mar; 63(3):1027-36. PubMed ID: 12631084 [Abstract] [Full Text] [Related]
15. [Morpho- and pathogenesis of nephrosclerosis: a clinico-morphological analysis]. Serov VV, Iargin SV. Ter Arkh; 1986 Mar; 58(8):4-9. PubMed ID: 3532411 [Abstract] [Full Text] [Related]
16. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study. Liang S, Le W, Liang D, Chen H, Xu F, Chen H, Liu Z, Zeng C. BMC Nephrol; 2016 Apr 11; 17():42. PubMed ID: 27066888 [Abstract] [Full Text] [Related]
17. Glomerular lesions in benign essential hypertension. A study of eight biopsy specimens with laboratory evidence suggestive of glomerular abnormalities. Katz SM, Lavin L, Swartz C. Arch Pathol Lab Med; 1979 Apr 11; 103(4):199-203. PubMed ID: 581847 [Abstract] [Full Text] [Related]
18. Nephrosclerosis: a term in quest of a disease. Meyrier A. Nephron; 2015 Apr 11; 129(4):276-82. PubMed ID: 25871843 [Abstract] [Full Text] [Related]
19. Does essential hypertension cause end-stage renal disease? Weisstuch JM, Dworkin LD. Kidney Int Suppl; 1992 May 11; 36():S33-7. PubMed ID: 1614065 [Abstract] [Full Text] [Related]
20. [Nephropathy associated with arterial hypertension: genes and Barker's hypothesis]. Zoccali C. G Ital Nefrol; 2002 May 11; 19(5):517-22. PubMed ID: 12439839 [Abstract] [Full Text] [Related] Page: [Next] [New Search]